The ISH Council would like to acknowledge the assistance of the following Corporate Members who are participating in the ISH and therefore helping to promote the advancement of scientific research and knowledge in hypertension and associated cardiovascular diseases.
Current Corporate Members
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets.
While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain.
For more information, please visit: daiichisankyo.com.
Founded in 1981, Microlife is one of the world leaders in the development and manufacturing of medical diagnostic equipment for home monitoring and professional use.
Not just one of two major brands worldwide supplier of electronic blood pressure measurement products, but also the first to deliver Afib screening within the convenience of daily-use blood pressure measurement devices. Microlife is committed to developing tools and devices embedded with medically-relevant technology to help doctors and patients achieve better results in health treatment and management, as well as in the prevention of illnesses. We invite you to join us and make a big stride - Empowering people to manage and promote their own health.
For more information, please visit: www.microlife.com
By looking beyond the technology, our real commitment lies in building healthy lives. We aim to provide a total healthcare management service, aimed at preventing and improving such increasingly common health problems as hypertension, respiratory problems, diabetes and obesity.